Rejuvenate Boimed
Rejuvenate Biomed is a science based healthy aging company developing prescription drugs in healthy aging by repositioning approved drugs.
Rejuvenate Boimed has raised €16M across 1 funding round from 2 investors, most recently a Series B round in Oct 2021. Based in Heusden, Belgium; active in Healthtech. Data as of 28 Oct 2026.
Heusden, Belgiumwww.rejuvenatebiomed.com/en ↗
Total raised
€16M
€15,700,000
Funding rounds
1
Investors
2
distinct backers
Active since
2021-10
latest 2021-10
Funding by year
EUR raised per yearRejuvenate Boimed — funding by year — interactive chart.
Data table
| Rejuvenate Boimed — funding by year | |
|---|---|
| 2021 | €16M |
Signals
High confidenceRaise-next likelihood9
base rate 48% for Series B
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-10-12 | Series B | €16M | Rejuveron,Vesalius Biocapital Partners | View deal → |
Investors
2Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Imec€2.5BBelgium · Deeptech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Kpler€1.0BBelgium · Software
Global coverage: FundingData